• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

_|ABSTRACT: An improved embryonated chicken egg model for the evaluation of antiviral drugs against influenza A virus|_

Giuseppe

Emeritus
(1.3): J Virol Methods. 2008 Jul 21. [Epub ahead of print]

An improved embryonated chicken egg model for the evaluation of antiviral drugs against influenza A virus.

Wang JX, Zhou JY, Yang QW, Chen Y, Li X, Piao YA, Li HY. - Department of Epidemiology, Public Health College, Harbin Medical University, Harbin, China.

Influenza is a serious global public health problem and an economic burden.

With the continual emergence of new influenza A virus strains, new antiviral drugs are needed urgently.

In this study, an improved embryonated chicken egg model for evaluating antiviral activity against Influenza A virus was developed.

In the model, the influenza A virus was injected into the allantoic cavity and ribavirin was injected into the albumen of the egg.

The levels of influenza A virus in the allantoic fluid was titrated by the hemagglutination test after incubation for 72h at 35.5 degrees C and 12h at 4 degrees C.

Ribavirin treatment at a dose of 25mg/kg to 100mg/kg decreased significantly the hemagglutination titers both of Influenza virus A/FM1, H1N1 (IVA1) (p<0.01) and influenza virus A/Wuhan/359/95, H3N2 (IVA3) (p<0.01).

In a time-dependent drug addition assay, significant efficacy of ribavirin against both IVA1 and IVA3 was observed when the drug was administered before and shortly after viral inoculation (p<0.01 or p<0.05).

In conclusion, ribavirin treatment showed significant antiviral activities against IVA1 and IVA3 in this model, suggesting that the improved model would be useful for evaluating the anti-influenza virus activity of potential inhibitors.
-
PMID: 18652846 [PubMed - as supplied by publisher
-------
 
Back
Top